Tips for Selecting Packaging for Pharmaceutical Drug Manufacturers - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Tips for Selecting Packaging for Pharmaceutical Drug Manufacturers
The author describes key considerations for drug manufacturers when evaluating packaging partners.

Pharmaceutical Technology
Volume 35, Issue 3

Differentiate with a unique delivery or administration system

Packaging can be a significant factor in the success of a drug product getting through the regulatory approval process smoothly and to the market quickly. How the product is going to be delivered should be determined based on the clinical application, but research and development is not the time to try a new or high-risk packaging material or system.

Pharmaceutical manufacturers should initially seek out reliable, low-risk packaging materials that are standardized and then apply a unique delivery system to differentiate and optimize delivery. Ideally, the same package should be used for containment from drug research through to commercialization phases.

In many cases, the goal is to move from a vial/stopper system to a prefillable syringe system or auto-injector. Selecting a material that can be used consistently throughout the drug development process, such as a cyclic olefin polymer, can help mitigate risk and reduce time to market. Since this material is plastic, it can be molded into a variety of shapes and sizes, enabling manufacturers to offer unique delivery or administration systems without the need to retest the material for interactions with the drug product.

Having the same material involved in bulk storage, vials, and delivery or administration systems provides consistency in the drug-material interface and minimizes contamination risk as the drug moves from research to clinical trials to commercialization.

Maintain focus on core business

Partnering with a component manufacturer can help drug companies maintain focus on their core business by eliminating the extra time, money, and staff associated with component preparation and sterilization.

For pharmaceutical manufacturers, eliminating the in-house component preparation process can be a cost-effective method of complying with new regulations and streamlining the fill process. By creating a lasting partnership with a packaging manufacturer, drug makers not only help to establish compliance and improve quality, but also have the ability to rely on expert advice and counsel throughout a drug's life cycle.

Containers and administration devices are integral to the safety and efficacy of drug therapies; consequently, the alignment of packaging manufacturers with drug development and production processes will enhance quality, and ultimately, patient safety.

Fran L. DeGrazio is vice-president of marketing and strategic business development at West Pharmaceutical Services, 101 Gordon Dr., Lionville, PA 19341, tel. 610.594.2900, fax 610.594.3000,


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here